New Haven, Connecticut 06520


Purpose:

The hypothesis of this study is that injection of botulinum toxin A into the muscles around the head (frontal, temporal, posterior neck, occipital) can reduce the intensity and frequency of migraine headaches by 50% and more and this effect is even more positive after second treatment.


Criteria:

Inclusion Criteria: - Adults 18 and older - Migraine for more than three months, that fail to respond to two or more major anti-migraine drug, meeting criteria of chronic migraine Exclusion Criteria: - Age below 18 - Pregnant or may become pregnant - Disease of neuromuscular junction or drugs that affect N-M junction - Allergy to Botox - Previous use of Botox for migraine by similar methodology


NCT ID:

NCT00660192


Primary Contact:

Principal Investigator
Bahman Jabbari, M.D.
Yale University

Diana Richardson, M.D.
Phone: (203) 737-1831
Email: diana.richardson@yale.edu


Backup Contact:

Email: laura.marshall@yale.edu
Laura Marshall
Phone: (203) 785-5420


Location Contact:

New Haven, Connecticut 06520
United States



There is no listed contact information for this specific location.

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: January 18, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.